Clinical Trials in Baltimore

Showing 561-580 of 23,476 trials

Strong Heart Water Study

NCT03725592

Develop and evaluate the effectiveness of multi-level participatory interventions in reducing arsenic exposure among American Indian (AI) communities from North and South Dakota who participated in the Strong Heart Study (SHS).

Arsenic Poisoning

Johns Hopkins Bloomberg School of Public Health57 participantsStarted Jul 2018

Baltimore, Maryland, United States

Active Not RecruitingPhase 3< 1 mile

A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer

NCT01946204

The purpose of this study is to evaluate the efficacy and safety of apalutamide in adult men with high-risk non-metastatic castration-resistant prostate cancer.

Prostatic Neoplasms

Aragon Pharmaceuticals, Inc.1,207 participantsStarted Oct 2013

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Chandler, Arizona, United States +376 more locations

Strong Heart Water Study

A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer

Find Trials by Condition in Baltimore

Human Upper Extremity Allotransplantation: F/U Protocol

Pain Self-Management and Treatment Engagement for Patients Taking Opioids

A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Recasting or Book Reading by Parents or Clinicians

A Clinical Trial for Participants With DEE to Assess Efficacy, Safety, Tolerability, and PK of Relutrigine

Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies (KL264-01)

High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer

Efficacy and Safety of Benralizumab in EGPA Compared to Mepolizumab.

A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)

Add-on Reparixin in Adult Patients With ARDS

To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer

A Phase 1 Study of AJ1-11095 in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)

Rhythm Control - Catheter Ablation With or Without Anti-arrhythmic Drug Control of Maintaining Sinus Rhythm Versus Rate Control With Medical Therapy and/or Atrio-ventricular Junction Ablation and Pacemaker Treatment for Atrial Fibrillation